The global female infertility diagnosis and treatment market is projected to grow at a CAGR of 4%, during the forecast period. Increasing infertility and changing lifestyle to drive the growth of the global female infertility diagnosis and treatment market. For instance, as per the estimation of the Centers for Disease Control and Prevention (CDC), in 2017, in the US, around 12.1% of women aged between 15-44 suffer from impaired fecundity, whereas, nearly 6.7% of married women in the same age group are infertile. This, in turn, is expected to propel the demand for female infertility diagnosis and treatment.

Request a free sample of our report on Female Infertility Diagnosis and Treatment Market: https://www.omrglobal.com/request-sample/female-infertility-market-size

Furthermore, the rising trends of surrogacy, growing infertility rate among females, new technologies to avoid multiple embryo implants are estimated to be the major factors that are contributing towards the growth of the market. However, there are certain factors that are restraining the growth of the market, such as the high cost of infertility treatment, low accuracy rate of the treatment. Moreover, the social stigma related to the infertility treatment is another factor that may hinder the global female infertility diagnosis and treatment market across the globe.

A full report of Female Infertility Diagnosis and Treatment Market is available at: https://www.omrglobal.com/industry-reports/female-infertility-market-size

Global Female Infertility Diagnosis and Treatment Market Segmentation

By Diagnosis

Ovulation Testing

Hysterosalpingography (HSG)

Hysteroscopy

Imaging Testing

Ovarian Reserve Testing

Hormonal Level Testing

Genetic Testing

Others (Laparoscopy)

By Treatment

Drugs

Surgery

Intrauterine Insemination (IUI)

Assisted Reproductive Technology (ART)

By End-User

Hospitals and Clinics

Homecare

Pathology and Diagnostic Centers

Regional Analysis

North America

United States

Canada

Europe

UK

Germany

Italy

Spain

France

Rest of Europe

Asia-Pacific

China

India

Japan

Rest of Asia-Pacific

Rest of the World

Company Profiles

Bayer AG

Clearblue, a company of SPD Swiss Precision Diagnostics GmbH

Cook Medical, Inc.

Eli Lilly & Co.

Esco Group

Fairhaven Health, LLC

Ferring B.V.

FIRST RESPONSE, a division of Church & Dwight Co., Inc.

FUJIFILM Irvine Scientific, Inc.

Genea Ltd.

For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/female-infertility-market-size

About us:

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visit https://www.omrglobal.com/

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: [email protected]

Contact no: +91 780-304-0404